205 related articles for article (PubMed ID: 7848103)
1. [Proliferative activity of basal cell and metatypical cell carcinoma of the skin].
Kazantseva IA; Khlebnikova AN; Babaev VR; Fager G
Arkh Patol; 1994; 56(4):35-8. PubMed ID: 7848103
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin.
Kazantseva IA; Khlebnikova AN; Babaev VR
Am J Dermatopathol; 1996 Feb; 18(1):35-42. PubMed ID: 8721589
[TBL] [Abstract][Full Text] [Related]
3. [Metatypical basal-cell carcinoma (MTC) or basosquamos carcinoma (BSC): surgical therapy].
Tarallo M; Cigna E; Fino P; Sorvillo V; Scuderi N
Ann Ital Chir; 2011; 82(5):389-94. PubMed ID: 21988047
[TBL] [Abstract][Full Text] [Related]
4. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
[TBL] [Abstract][Full Text] [Related]
5. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
6. The detection of basal cell determinants in human basal cell carcinomas using two different monoclonal antibodies.
Habets JM; Tank B; Vuzevski VD; van Reede EC; Stolz E; van Joost T
Acta Derm Venereol; 1987; 67(5):391-8. PubMed ID: 2448989
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the skin: dual differentiations to rare basosquamous and spindle cell variants.
Mitsuhashi T; Itoh T; Shimizu Y; Ban S; Ogawa F; Hirose T; Shimizu M
J Cutan Pathol; 2006 Mar; 33(3):246-52. PubMed ID: 16466514
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in basal cell carcinomas.
Stoebner PE; Le Gallic L; Berthe ML; Boulle N; Lallemant B; Marque M; Gaspard C; Delfour C; Lavabre-Bertrand T; Martinez J; Meunier L
Exp Dermatol; 2008 Nov; 17(11):908-15. PubMed ID: 18341568
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
11. Oral carcinoma in situ. Its progression to squamous, basosquamous, and basal-cell carcinoma.
Fresko D; Lazarus SS
Arch Pathol Lab Med; 1981 Jan; 105(1):15-9. PubMed ID: 6893909
[TBL] [Abstract][Full Text] [Related]
12. Ki67 as a biologic marker of basal cell carcinoma: a retrospective study.
Kramer E; Herman O; Frand J; Leibou L; Schreiber L; Vaknine H
Isr Med Assoc J; 2014 Apr; 16(4):229-32. PubMed ID: 24834759
[TBL] [Abstract][Full Text] [Related]
13. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
14. Merkel cell-poor trichoblastoma with basal cell carcinoma-like foci.
Misago N; Satoh T; Miura Y; Nagase K; Narisawa Y
Am J Dermatopathol; 2007 Jun; 29(3):249-55. PubMed ID: 17519622
[TBL] [Abstract][Full Text] [Related]
15. [Desmoplastic trichoepithelioma: a clinicopathological study, including a comparison with morpheiform basal cell carcinoma].
Mitcov M; Scrivener Y; Cribier B
Ann Dermatol Venereol; 2009; 136(6-7):501-7. PubMed ID: 19560610
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer.
Cohen PR; Schulze KE; Nelson BR
Dermatol Surg; 2006 Apr; 32(4):542-51. PubMed ID: 16681663
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis of basalioma and metatypical skin cancer].
Kazantseva IA; Bogatyreva II; Vavilov AM; Parshikova SM
Arkh Patol; 1983; 45(6):35-9. PubMed ID: 6625927
[TBL] [Abstract][Full Text] [Related]
18. Patients with both basal and squamous cell carcinomas are at a lower risk of further basal cell carcinomas than patients with only a basal cell carcinoma.
Ramachandran S; Rajaratnam R; Smith AG; Lear JT; Strange RC
J Am Acad Dermatol; 2009 Aug; 61(2):247-51. PubMed ID: 19481292
[TBL] [Abstract][Full Text] [Related]
19. Comparative morphometric analysis of primary versus recurrent basal cell carcinoma and of histological subtypes. Significance of morphometry of the nuclei.
Bierhoff E; Appel K; Appel T; Buettner R; Wardelmann E
Anticancer Res; 2003; 23(3B):2697-700. PubMed ID: 12894560
[TBL] [Abstract][Full Text] [Related]
20. Sarcomatoid basal cell carcinoma--predilection for osteosarcomatous differentiation: a series of 11 cases.
Mc Menamin ME; Goh SG; Poblet E; Gostelow BE; Robson A; Calonje E
Am J Surg Pathol; 2006 Oct; 30(10):1299-308. PubMed ID: 17001162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
